Effect of miR-34a on resistance to sunitinib in breast cancer by regulating the Wnt/ β-catenin signaling pathway.

CONCLUSIONS: MiR-34a affects the sensitivity to sunitinib in breast cancer by regulating the Wnt/β-catenin signaling pathway. PMID: 30779084 [PubMed - in process]
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research